Finding the optimal cutoff value for amyloid β positivity using the iterative outlier method and concordance rate
Hang-Rai Kim, Yeong Sim Choe, Seung Hwan Moon, Hee Jin Kim, Hyemin Jang, Duk L.Na, Seongbeom Park, Sang Won Seo
Precis Future Med. 2021;5(2):83-89.   Published online 2021 Jun 8     DOI: https://doi.org/10.23838/pfm.2021.00023
Citations to this article as recorded by Crossref logo
Independent effects of amyloid and vascular markers on long‐term functional outcomes: An 8‐year longitudinal study of subcortical vascular cognitive impairment
Sung Hoon Kang, Sook‐young Woo, Seonwoo Kim, Jun Pyo Kim, Hyemin Jang, Seong‐Beom Koh, Duk L. Na, Hee Jin Kim, Sang Won Seo
European Journal of Neurology.2022; 29(2): 413.     CrossRef
Longitudinal amyloid cognitive composite in preclinical Alzheimer’s disease
Young Ju Kim, Alice Hahn, Yu Hyun Park, Duk L. Na, Juhee Chin, Sang Won Seo
European Journal of Neurology.2022; 29(4): 980.     CrossRef
Ethnic differences in the frequency of β-amyloid deposition in cognitively normal individuals
Jaeho Kim, Sang-Hyuk Jung, Yeong Sim Choe, Soyeon Kim, Beomsu Kim, Hang-Rai Kim, Sang Joon Son, Chang Hyung Hong, Duk L. Na, Hee Jin Kim, Soo-Jin Cho, Hong-Hee Won, Sang Won Seo
Neurobiology of Aging.2022; 114: 27.     CrossRef
Performance of the plasma Aβ42/Aβ40 ratio, measured with a novel HPLC-MS/MS method, as a biomarker of amyloid PET status in a DPUK-KOREAN cohort
Hyemin Jang, Ji Sun Kim, Hye Joo Lee, Chi-Hun Kim, Duk L. Na, Hee Jin Kim, José Antonio Allué, Leticia Sarasa, Sergio Castillo, Pedro Pesini, John Gallacher, Sang Won Seo
Alzheimer's Research & Therapy.2021;[Epub]     CrossRef